Gloriana Therapeutics Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Out of Business

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Out of Business

Gloriana Therapeutics General Information

Description

Developer of transformational therapeutics designed to provide treatment for neurological diseases. The company's therapeutics identify novel neurotrophic proteins with therapeutic effects in the nervous system and develop technologies to target protein therapeutics across the blood-brain barrier and directly to diseased nerve cells, enabling healthcare professionals to initiate treatment and potentially lead to a cure for neurological disorders.

Contact Information

Formerly Known As
NsGene
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 130 Franklin Street
  • Warren, RI 02885
  • United States
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 130 Franklin Street
  • Warren, RI 02885
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gloriana Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Out of Business 17-Sep-2024 Completed Out of Business
12. Later Stage VC 29-Nov-2019 Cancelled Product Development
11. Secondary Transaction - Private 01-Nov-2017 Completed Product Development
10. Grant 21-Nov-2013 Completed Product Development
9. Later Stage VC 01-Dec-2009 Completed Product Development
8. Later Stage VC 20-May-2008 Completed Product Development
7. Later Stage VC 02-May-2005 Completed Product Development
6. Grant 07-Jul-2004 Completed Product Development
5. Later Stage VC 05-Jan-2004 $2.98M $19.4M Completed Product Development
4. Early Stage VC 29-Dec-2003 $2.98M $16.4M Completed Startup
To view Gloriana Therapeutics’s complete valuation and funding history, request access »

Gloriana Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
D Shares
To view Gloriana Therapeutics’s complete cap table history, request access »

Gloriana Therapeutics Patents

Gloriana Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020417255-A1 Mammalian cells secreting gdnf and their therapeutic use Inactive 29-Dec-2019
CA-3163253-A1 Mammalian cells secreting gdnf and their therapeutic use Active 29-Dec-2019
CA-3163253-C Mammalian cells secreting gdnf and their therapeutic use Active 29-Dec-2019
EP-4081262-A1 Mammalian cells secreting gdnf and their therapeutic use Inactive 29-Dec-2019
EP-4081262-A4 Mammalian cells secreting gdnf and their therapeutic use Inactive 29-Dec-2019 C12M25/02
To view Gloriana Therapeutics’s complete patent history, request access »

Gloriana Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gloriana Therapeutics Investments (2)

Gloriana Therapeutics’s most recent deal was a Seed Round with Hoba Therapeutics. The deal was made on 22-May-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hoba Therapeutics 22-May-2019 Seed Round Drug Discovery
ZGene 17-Apr-2002 Seed Round Biotechnology
To view Gloriana Therapeutics’s complete investments history, request access »

Gloriana Therapeutics FAQs

  • When was Gloriana Therapeutics founded?

    Gloriana Therapeutics was founded in 1999.

  • Where is Gloriana Therapeutics headquartered?

    Gloriana Therapeutics is headquartered in Warren, RI.

  • What is the size of Gloriana Therapeutics?

    Gloriana Therapeutics has 13 total employees.

  • What industry is Gloriana Therapeutics in?

    Gloriana Therapeutics’s primary industry is Biotechnology.

  • Is Gloriana Therapeutics a private or public company?

    Gloriana Therapeutics is a Private company.

  • What is Gloriana Therapeutics’s current revenue?

    The current revenue for Gloriana Therapeutics is .

  • How much funding has Gloriana Therapeutics raised over time?

    Gloriana Therapeutics has raised $37M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process